Beratungsgespräch in der Sprechstunde

Geriatric medicine

On this site you will find information about clinical trials in the field of geriatric medicine

You are here:

Clinical trials

In our capacity as a research institution our goal is to develop and progress new therapies and treatments. Clinical trials are a crucial part of this process. Participation is voluntary and the trials do not affect our other diagnostic and therapeutic services.

All clinical trials we conduct are placebo-controlled. One group of patients receives the test treatment while another group is treated with a placebo.

In addition to this safeguard, trials are double-blind: neither the participants nor the persons administering the trial are aware which is the test group and which is the placebo group. This ensures impartiality and strengthens the quality of the results. Each trial includes follow-up study.

Who can participate in trials?

A variety of criteria must be met for participation, including age, severity of the diagnosis and the general health of the participant. These checks are carried out on an individual basis.

For more information about forthcoming clinical studies, and to find out how you can take part, please contact us to arrange a consultation.

Pioneering new approaches

In this interview with German public broadcaster Deutsche Welle, the head of Geriatric Medicine at the Charité Dr. Peters discusses new approaches for treating Alzheimers. Watch the interview.

Clinical trials to participate in:

Publicly funded studies

DZNE DESCRIBE-FTD observational study

DZNE DESCRIBE-FTD observational study
Seeking: healthy control subjects; patients with a variant of frontotemporal lobar degeneration (PPA, PNFA, LPA, semantic dementia, behavioural FTLD)

Sponsor: German Center for Neurodegenerative Disease (DZNE)
Now recruiting

DANCER observational study

DANCER observational study
Seeking: Subjects without memory problems/evidence of neurodegenerative or cerebrovascular disease (age ≥ 50 years)

Sponsor: German Center for Neurodegenerative Disease (DZNE)
Now recruiting

CBT-late│Interventional study

CBT-late│Interventional study

Seeking: Persons diagnosed with late life depression (age ≥ 60 years)


Sponsor: BMBF

Now recruiting

Studies funded in co-operation with industry partners:

GRADUATE I - Hoffmann-La Roche Therapy trial Phase III

GRADUATE I - Hoffmann-La Roche Therapy trial Phase III
Seeking: Patients with mild cognitive impairment (MCI) due to Alzheime's disease and patients with mild Alzheimer's dementia
Sponsor: Hoffmann-La Roche
Now recruiting

Clinical trials enquiries

Steglitz on CBF

+49 30 450 517 688

+49 30 450 517 977

Buch on CBB– ECRC

+49 30 450 540 077

+49 30 450 540 997